This is an excerpt from Second Opinion, a weekly roundup of eclectic and under-the-radar health and medical science news emailed to subscribers every Saturday morning. If you haven’t subscribed yet, you can do that by clicking here. For Canadians who remember the face masks, quarantines and airport screenings of the SARS epidemic, a mysteriousRead More →

Fewer reports of vaping illnesses are coming in, but U.S. health officials say they are not sure what to make of it. The U.S. Centers for Disease Control and Prevention said 125 additional cases were reported in the last week, bringing the total to 1,604 in this year’s outbreak. That includesRead More →

Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination. The French company Friday joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug. In September, the U.S. Food and Drug Administration said a potentially cancer-causingRead More →

When people who couldn’t afford essential medications to lower blood pressure or control diabetes received the treatments free, their health improved, according to a randomized trial that could inform Canada’s pharmacare discussion. Medicines are not universally publicly funded in Canada the way hospitalization and physician care are. Dr. Nav Persaud ofRead More →